USPTO Patent Application: Thyroid Hormone Delivery Device
Summary
The USPTO has published a patent application (US20260083906A1) for a thyroid hormone delivery device. The application describes a subcutaneous implantable device with a microprocessor and precision pump for continuous thyroxine delivery, aiming to enhance patient compliance and metabolic control.
What changed
This document is a USPTO patent application (US20260083906A1) filed on September 21, 2024, for a novel thyroid hormone delivery device. The proposed device is designed for subcutaneous implantation and features a reservoir regulated by an embedded microprocessor and precision pump to ensure continuous and precisely dosed delivery of thyroxine at regular intervals.
While this is a patent application and not a regulation, it indicates potential future developments in medical devices for endocrine therapy. Companies involved in pharmaceutical manufacturing or medical device development, particularly those focused on drug delivery systems, should be aware of this technological advancement. There are no immediate compliance obligations or deadlines associated with this patent application.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Mechanisms for Thyroid Hormone Delivery
Application US20260083906A1 Kind: A1 Mar 26, 2026
Inventors
Brian Haney
Abstract
The present disclosure provides methods and a device for thyroxine delivery. This device is designed for subcutaneous implantation to ensure continuous delivery of thyroxine. It features a reservoir regulated by an embedded microprocessor with advanced signal software. The software triggers a precision pump to release a specific dose of thyroxine at regular intervals. This system enhances patient compliance and maintains optimal metabolic control.
CPC Classifications
A61M 5/14276 A61K 31/195 A61M 5/172
Filing Date
2024-09-21
Application No.
18892392
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.